369 related articles for article (PubMed ID: 37369991)
1. A Mendelian randomization study on causal effects of 25(OH) vitamin D levels on diabetic nephropathy.
He M; Yang T; Zhou P; Bu P; Yang X; Zou Y; Zhong A
BMC Nephrol; 2023 Jun; 24(1):192. PubMed ID: 37369991
[TBL] [Abstract][Full Text] [Related]
2. Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study.
Yan S; Wang H; Feng B; Ye L; Chen A
Front Immunol; 2024; 15():1332757. PubMed ID: 38533501
[TBL] [Abstract][Full Text] [Related]
3. Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study.
Lu J; Liu X; Jiang S; Kan S; An Y; Zheng C; Li X; Liu Z; Xie G
J Clin Endocrinol Metab; 2022 May; 107(6):1599-1608. PubMed ID: 35191949
[TBL] [Abstract][Full Text] [Related]
4. [Vitamin supply of patients with type 2 diabetes mellitus complicated by nephropathy].
Vrzhesinskaya OA; Leonenko SN; Kodentsova VM; Beketova NA; Kosheleva OV; Pilipenko VV; Plotnikova OA; Alekseeva RI; Sharafetdinov KK
Vopr Pitan; 2022; 91(2):58-71. PubMed ID: 35596636
[TBL] [Abstract][Full Text] [Related]
5. Negative effect of vitamin D on kidney function: a Mendelian randomization study.
Teumer A; Gambaro G; Corre T; Bochud M; Vollenweider P; Guessous I; Kleber ME; Delgado GE; Pilz S; März W; Barnes CLK; Joshi PK; Wilson JF; de Borst MH; Navis G; van der Harst P; Heerspink HJL; Homuth G; Endlich K; Nauck M; Köttgen A; Pattaro C; Ferraro PM
Nephrol Dial Transplant; 2018 Dec; 33(12):2139-2145. PubMed ID: 29718335
[TBL] [Abstract][Full Text] [Related]
6. Separating the effects of life course adiposity on diabetic nephropathy: a comprehensive multivariable Mendelian randomization study.
Zhang H; Zhang Q; Song Y; Wang L; Cai M; Bao J; Yu Q
Front Endocrinol (Lausanne); 2024; 15():1285872. PubMed ID: 38390197
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization study supports the causal association between serum cystatin C and risk of diabetic nephropathy.
Feng B; Lu Y; Ye L; Yin L; Zhou Y; Chen A
Front Endocrinol (Lausanne); 2022; 13():1043174. PubMed ID: 36482996
[TBL] [Abstract][Full Text] [Related]
8. Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study.
Xiao J; Lv J; Wang S; Zhou Y; Chen L; Lu J; Zhang X; Wang X; Gu Y; Lu Q
BMC Geriatr; 2021 Jun; 21(1):391. PubMed ID: 34187381
[TBL] [Abstract][Full Text] [Related]
9. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.
Panduru NM; Sandholm N; Forsblom C; Saraheimo M; Dahlström EH; Thorn LM; Gordin D; Tolonen N; Wadén J; Harjutsalo V; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2015 Jun; 38(6):1130-7. PubMed ID: 25784666
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.
Liu N; Wang G; Liu C; Liu J; Huang S; Zhou Y; Xiao E
Diabetes Obes Metab; 2023 Feb; 25(2):365-376. PubMed ID: 36181433
[TBL] [Abstract][Full Text] [Related]
11. Genetically increased circulating 25(OH)D level reduces the risk of type 2 diabetes in subjects with deficiency of vitamin D: A large-scale Mendelian randomization study.
Xu Y; Zhou Y; Liu J; Wang C; Qu Z; Wei Z; Zhou D
Medicine (Baltimore); 2020 Dec; 99(51):e23672. PubMed ID: 33371106
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study.
Manousaki D; Harroud A; Mitchell RE; Ross S; Forgetta V; Timpson NJ; Smith GD; Polychronakos C; Richards JB
PLoS Med; 2021 Feb; 18(2):e1003536. PubMed ID: 33630834
[TBL] [Abstract][Full Text] [Related]
13. Causality between sarcopenia and diabetic nephropathy: a bidirectional Mendelian randomization study.
Ren L; Wang Y; Ju F; Sun M; Gang X; Wang G
Front Endocrinol (Lausanne); 2023; 14():1188972. PubMed ID: 37284212
[TBL] [Abstract][Full Text] [Related]
14. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study.
Ye Z; Sharp SJ; Burgess S; Scott RA; Imamura F; ; Langenberg C; Wareham NJ; Forouhi NG
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):35-42. PubMed ID: 25281353
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D, prediabetes and type 2 diabetes: bidirectional Mendelian randomization analysis.
Wang N; Wang C; Chen X; Wan H; Chen Y; Chen C; Han B; Lu Y
Eur J Nutr; 2020 Jun; 59(4):1379-1388. PubMed ID: 31076857
[TBL] [Abstract][Full Text] [Related]
16. Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study.
Kjaergaard AD; Teumer A; Witte DR; Stanzick KJ; Winkler TW; Burgess S; Ellervik C
Clin Chem; 2022 Mar; 68(3):461-472. PubMed ID: 34922334
[TBL] [Abstract][Full Text] [Related]
17. The association of alanine aminotransferase and diabetic microvascular complications: A Mendelian randomization study.
Bi Y; Liu Y; Wang H; Tian S; Sun C
Front Endocrinol (Lausanne); 2023; 14():1104963. PubMed ID: 36742400
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: A randomized, double-blind clinical trial.
Liyanage P; Lekamwasam S; Weerarathna TP; Liyanage C
J Postgrad Med; 2018; 64(1):10-15. PubMed ID: 29386413
[TBL] [Abstract][Full Text] [Related]
19. Could vitamin D reduce obesity-associated inflammation? Observational and Mendelian randomization study.
Palaniswamy S; Gill D; De Silva NM; Lowry E; Jokelainen J; Karhu T; Mutt SJ; Dehghan A; Sliz E; Chasman DI; Timonen M; Viinamäki H; Keinänen-Kiukaanniemi S; Hyppönen E; Herzig KH; Sebert S; Järvelin MR
Am J Clin Nutr; 2020 May; 111(5):1036-1047. PubMed ID: 32232398
[TBL] [Abstract][Full Text] [Related]
20. Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study.
Liyanage UE; Law MH; ; Barrett JH; Iles MM; MacGregor S
Br J Dermatol; 2020 Jan; 182(1):97-103. PubMed ID: 31218665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
